Hanmi Pharmaceutical Co., Ltd. - 10%+ Owner at Aptose Biosciences Inc.

Issuer-level insider activity

Role
10%+ Owner
Issuer ticker
APTOF
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Company
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Hanmi Pharmaceutical Co., Ltd. since 27 Aug 2025

Reported holdings for Hanmi Pharmaceutical Co., Ltd. in Aptose Biosciences Inc.

Form 4 holding 10%+ Owner

Aptose Biosciences Inc.

Security class
Common Shares
Shares / value
508,710
Estimated value
$101,742
Report date
18 Mar 2025
Price
$0.2000
Ownership
Direct

Transaction history for Hanmi Pharmaceutical Co., Ltd. in Aptose Biosciences Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .